Corporate Headquarters
Vector Laboratories, Inc.
6737 Mowry Ave
Newark, CA 94560
United States
NAT2 is an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second arylamine N-acetyltransferase gene (NAT1) is located near this gene (NAT2).
Gene Name: | N-acetyltransferase 2 (arylamine N-acetyltransferase) |
Synonyms: | NAT2, AAC2, PNAT, Arylamide acetylase 2, N-acetyltransferase type 2, NAT-2 |
Target Sequences: | NM_000015 NP_000006.2 P11245 |
If you do not find the reagent or information you require, please contact Customer.Support@LSBio.com to inquire about additional products in development.